HK1201439A1 - Method of treating or reducing efp efp - Google Patents

Method of treating or reducing efp efp

Info

Publication number
HK1201439A1
HK1201439A1 HK15101853.7A HK15101853A HK1201439A1 HK 1201439 A1 HK1201439 A1 HK 1201439A1 HK 15101853 A HK15101853 A HK 15101853A HK 1201439 A1 HK1201439 A1 HK 1201439A1
Authority
HK
Hong Kong
Prior art keywords
efp
treating
reducing
reducing efp
efp efp
Prior art date
Application number
HK15101853.7A
Other languages
English (en)
Chinese (zh)
Inventor
Susan G Emeigh Hart
Original Assignee
Auxilium Int Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auxilium Int Holdings Inc filed Critical Auxilium Int Holdings Inc
Publication of HK1201439A1 publication Critical patent/HK1201439A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15101853.7A 2011-10-21 2015-02-23 Method of treating or reducing efp efp HK1201439A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161549863P 2011-10-21 2011-10-21
PCT/US2012/061063 WO2013059619A1 (fr) 2011-10-21 2012-10-19 Procédé de traitement ou de réduction de l'efp

Publications (1)

Publication Number Publication Date
HK1201439A1 true HK1201439A1 (en) 2015-09-04

Family

ID=48141393

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101853.7A HK1201439A1 (en) 2011-10-21 2015-02-23 Method of treating or reducing efp efp

Country Status (15)

Country Link
US (2) US20140335072A1 (fr)
EP (2) EP3581199B1 (fr)
JP (5) JP2014530873A (fr)
AU (5) AU2012325941A1 (fr)
BR (1) BR112014009785B1 (fr)
CA (1) CA2852942C (fr)
DK (2) DK2768523T3 (fr)
ES (2) ES2953560T3 (fr)
FI (1) FI3581199T3 (fr)
HK (1) HK1201439A1 (fr)
HU (2) HUE044650T2 (fr)
MX (2) MX2014004792A (fr)
PL (1) PL3581199T3 (fr)
PT (2) PT2768523T (fr)
WO (1) WO2013059619A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ766918A (en) 2012-01-12 2023-03-31 Auxilium Int Holdings Inc Clostridium histolyticum enzymes and methods for the use thereof
JP2015521169A (ja) 2012-05-01 2015-07-27 プロテオリース リミテッド 抜歯する方法
EP2968484B1 (fr) 2013-03-15 2020-11-25 BioSpecifics Technologies Corporation Procédé et produit de traitement pour fibroïdes utérins au moyen de collagénase purifiée
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
EP3589204A1 (fr) 2017-03-01 2020-01-08 Endo Ventures Limited Appareil et procédé d'évaluation et de traitement de la cellulite
KR20240001279A (ko) * 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
WO2020021330A2 (fr) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Techniques d'injection pour le traitement de la cellulite
WO2020021332A2 (fr) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Techniques d'injection pour le traitement de la cellulite
WO2020023406A1 (fr) * 2018-07-23 2020-01-30 Nc8, Inc. Système et procédés de traitement de la cellulite
CA3112437A1 (fr) * 2018-09-18 2020-03-26 Endo Global Aesthetics Limited Compositions et procedes pour le traitement de la cellulite
MX2021008017A (es) * 2019-01-06 2021-08-05 Endo Global Aesthetics Ltd Formulaciones de colagenasa y metodos de produccion de las mismas.
CA3157517A1 (fr) 2019-10-15 2021-04-22 The Johns Hopkins University Traitement de fibromes uterins a l'aide de collagenase purifiee
US20210244642A1 (en) * 2020-02-10 2021-08-12 Simeon Wall, Jr. Cellulite eradication methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US6958150B2 (en) * 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
ATE521355T1 (de) * 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (fr) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Procédés de traitement de la cellulite
US8617543B2 (en) * 2007-02-14 2013-12-31 Yolare Pharmaceuticals, LLC Modified mutant collagenase and its use in fat melting and in scar reduction

Also Published As

Publication number Publication date
HUE044650T2 (hu) 2019-11-28
ES2953560T3 (es) 2023-11-14
AU2016202026A1 (en) 2016-04-21
AU2012325941A1 (en) 2014-05-15
DK3581199T3 (da) 2023-09-04
WO2013059619A1 (fr) 2013-04-25
AU2017248451A1 (en) 2017-11-02
HUE063599T2 (hu) 2024-01-28
EP3581199A1 (fr) 2019-12-18
ES2741476T3 (es) 2020-02-11
NZ737403A (en) 2020-05-29
CA2852942A1 (fr) 2013-04-25
BR112014009785B1 (pt) 2020-06-30
CA2852942C (fr) 2023-01-10
BR112014009785A2 (pt) 2017-04-25
JP2022123073A (ja) 2022-08-23
EP2768523A1 (fr) 2014-08-27
JP2020158521A (ja) 2020-10-01
MX2014004792A (es) 2015-08-14
JP2024123126A (ja) 2024-09-10
BR112014009785A8 (pt) 2020-02-27
AU2020200763B2 (en) 2022-05-26
EP2768523B1 (fr) 2019-05-22
JP2014530873A (ja) 2014-11-20
NZ759819A (en) 2020-11-27
DK2768523T3 (da) 2019-07-22
MX2019007779A (es) 2019-09-04
EP3581199B1 (fr) 2023-05-31
US20140335072A1 (en) 2014-11-13
EP2768523A4 (fr) 2015-04-22
AU2020200763A1 (en) 2020-02-20
US20240216485A1 (en) 2024-07-04
PT3581199T (pt) 2023-08-31
NZ624057A (en) 2016-08-26
NZ722722A (en) 2019-05-31
FI3581199T3 (fi) 2023-08-18
AU2017248451B2 (en) 2019-11-14
NZ769098A (en) 2022-03-25
PL3581199T3 (pl) 2023-09-11
PT2768523T (pt) 2019-08-29
JP2018027968A (ja) 2018-02-22
AU2022202987A1 (en) 2022-05-26

Similar Documents

Publication Publication Date Title
EP2773754A4 (fr) Méthode de traitement
GB201110095D0 (en) Method of treatment
HK1201439A1 (en) Method of treating or reducing efp efp
EP2723384A4 (fr) Traitement de protéinopathies
EP2717855A4 (fr) Procédés de traitement
GB201018147D0 (en) Method of treatment
GB201003920D0 (en) Method of treatment
PT2701707T (pt) Método de tratamento de discinésia
IL229706A0 (en) A method for treating the effects of a stroke
SG11201400256PA (en) Water treatment method
EP2531259A4 (fr) Procédé de traitement de la sclérose en plaques
EP2709466A4 (fr) Méthode de traitement du miel
EP2585103A4 (fr) Méthode de traitement
GB201018149D0 (en) Method of treatment
GB201105523D0 (en) Treatment method
EP2791324A4 (fr) Procédé de traitement
GB201020015D0 (en) Method of treatment
GB201102475D0 (en) Method of reducing offset
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201005071D0 (en) Method of treatment
GB201003917D0 (en) Method of treatment
GB201000318D0 (en) Method of treatment